Tenoxicam, developed by Roche in 1976, is a type of nonsteroidal anti-inflammatory drug (NSAID) utilized for relieving inflammation and pain from muscle or joint injuries.
Tenoxicam, a non-selective COX inhibitor in the oxicam subgroup of NSAIDs, provides rapid analgesic, anti-inflammatory, and antipyretic effects, making it safe and ideal for managing rheumatoid conditions, musculoskeletal disorders, and postoperative pain.
Comments (0)